title: Editorial Comment to Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients.
authors.affiliation: Medical Oncology Unit, Istituto Neurotraumatologico Italiano (I.N.I.), Rome, Italy. antoniorozzi@virgilio.it.
authors.forename: Antonio
authors.initials: A
authors.lastname: Rozzi
authors.affiliation: Medical Oncology Unit, Istituto Neurotraumatologico Italiano (I.N.I.), Rome, Italy.
authors.forename: Gaetano
authors.initials: G
authors.lastname: Lanzetta
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009325:Nausea / Q000517:prevention & control*; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D014571:Urologic Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000517:prevention & control*
chemical_list: D000932:Antiemetics; D012702:Serotonin Antagonists